From crisis to competitiveness: The re-rating of Chilean salmon

As the world’s second-largest salmon producer after Norway, Chile has helped shape global salmon aquaculture, but its growth has never been linear. Disease outbreaks, harmful algal blooms, and regulatory uncertainty repeatedly exposed the limits of rapid expansion without sufficient biological control. But after decades of boom, crisis, and recovery, Chile’s salmon industry is entering a more promising phase.

Today, the industry looks more disciplined. Atlantic salmon mortality has improved, harvest weights are rising, and investment in better smolt, genetics, vaccines, and farming technology has strengthened Chile’s cost position. The key question is no longer whether Chile can grow but whether it can make growth biologically repeatable.

But Chile is not returning to the unchecked expansion of the past. The opportunity now is more valuable: to build a steadier, more professional, and more investable salmon industry, driven by better biology, smarter diversification, and clearer regulations.

Part of that diversification includes Coho salmon, which adds a second, increasingly important growth story. Once seen as a niche product mainly for Japan, coho is becoming a strategic advantage: faster-growing, more resistant to sea lice, cheaper to produce, and increasingly accepted in new markets. Its development gives Chile valuable species, market, and operational diversification.

Additionally, politics may now provide another tailwind. A more industry-friendly government is expected to reduce bureaucracy, speed up permitting, and unlock stalled concessions and farm relocations. If implemented sensibly, these reforms could lower production costs and support more consistent supply growth at a time when other salmon-producing regions face tighter biological, environmental, and tax constraints.

The outlook is therefore constructive – but not without risk. The US remains a critical market, Japan is still important for coho, and China and Latin America offer longer-term potential. Yet climate events, algae blooms, oxygen issues, tariff risk, and environmental scrutiny remain real constraints.